A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor

Clinical trial NCT01128842 · COMPLETED

Trial details

NCT number: NCT01128842
Sponsor: Puma Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2010-04-01
Primary completion: 2011-03-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.